Douglas E. Onsi - 23 Aug 2023 Form 4 Insider Report for LEAP THERAPEUTICS, INC. (LPTX)

Role: CEO,CFO,Pres.,GC,Treas.,&Sec., Director
Signature: /s/ Douglas E. Onsi
Issuer symbol: LPTX
Transactions as of: 23 Aug 2023
Net transactions value: $0
Form type: 4
Filing time: 25 Aug 2023, 17:30:56 UTC
Previous filing: 04 Apr 2023
Next filing: 30 Jan 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LPTX	Employee Stock Option (Right to Buy)	Award	$0	+140,000		$0.000000	140,000	23 Aug 2023	Common Stock	140,000	$2.21	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on September 23, 2023 and an additional of such monthly installments vesting on the 23rd day of each calendar month thereafter.

Content

The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on September 23, 2023 and an additional of such monthly installments vesting on the 23rd day of each calendar month thereafter.